CN119907695A - 用于成像和靶向放疗的新型小胃泌素衍生的胆囊收缩素2受体结合分子 - Google Patents

用于成像和靶向放疗的新型小胃泌素衍生的胆囊收缩素2受体结合分子 Download PDF

Info

Publication number
CN119907695A
CN119907695A CN202380067423.2A CN202380067423A CN119907695A CN 119907695 A CN119907695 A CN 119907695A CN 202380067423 A CN202380067423 A CN 202380067423A CN 119907695 A CN119907695 A CN 119907695A
Authority
CN
China
Prior art keywords
dota
glu
sifa
cck
trp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380067423.2A
Other languages
English (en)
Chinese (zh)
Inventor
T·京特
N·霍尔茨莱特纳
H·J·韦斯特
C·拉帕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Augsburg
Technical University of Munich
Original Assignee
University Augsburg
Technical University of Munich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Augsburg, Technical University of Munich filed Critical University Augsburg
Publication of CN119907695A publication Critical patent/CN119907695A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
CN202380067423.2A 2022-09-20 2023-05-19 用于成像和靶向放疗的新型小胃泌素衍生的胆囊收缩素2受体结合分子 Pending CN119907695A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22196630 2022-09-20
EP22196630.2 2022-09-20
PCT/EP2023/063469 WO2024061483A1 (en) 2022-09-20 2023-05-19 Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy

Publications (1)

Publication Number Publication Date
CN119907695A true CN119907695A (zh) 2025-04-29

Family

ID=83994946

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380067423.2A Pending CN119907695A (zh) 2022-09-20 2023-05-19 用于成像和靶向放疗的新型小胃泌素衍生的胆囊收缩素2受体结合分子

Country Status (9)

Country Link
EP (2) EP4590347A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025532619A (cg-RX-API-DMAC7.html)
KR (1) KR20250073200A (cg-RX-API-DMAC7.html)
CN (1) CN119907695A (cg-RX-API-DMAC7.html)
AU (1) AU2023345654A1 (cg-RX-API-DMAC7.html)
CA (1) CA3264385A1 (cg-RX-API-DMAC7.html)
IL (1) IL319379A (cg-RX-API-DMAC7.html)
MX (1) MX2025003151A (cg-RX-API-DMAC7.html)
WO (1) WO2024061483A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12642876B1 (en) 2025-10-30 2026-06-02 Perspective Therapeutics, Inc. Cholecystokinin-2 receptor targeted compounds and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3412303A1 (en) * 2017-06-08 2018-12-12 Medizinische Universität Innsbruck Improved pharmacokinetics and cholecystokinin-2 receptor (cck2r) targeting for diagnosis and therapy
KR20240027896A (ko) * 2017-07-28 2024-03-04 테크니쉐 우니베르지테트 뮌헨 이중 모드 방사성 트레이서 및 치료법
EP4023250A1 (en) * 2021-01-04 2022-07-06 Technische Universität München Dual mode radiotracer and -therapeutics

Also Published As

Publication number Publication date
KR20250073200A (ko) 2025-05-27
CA3264385A1 (en) 2024-03-28
JP2025532619A (ja) 2025-10-01
AU2023345654A1 (en) 2025-02-27
WO2024061483A1 (en) 2024-03-28
MX2025003151A (es) 2025-04-02
EP4590347A1 (en) 2025-07-30
IL319379A (en) 2025-05-01
EP4631959A3 (en) 2025-12-17
EP4631959A2 (en) 2025-10-15

Similar Documents

Publication Publication Date Title
CN111132700B (zh) 双模放射性示踪剂与治疗剂
CN103533963B (zh) 用通过nota络合的[18]氟化铝标记的her2结合肽
TWI878344B (zh) 放射性標記grpr拮抗劑之方法及其套組
AU2019469641B2 (en) Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders
CN103402550B (zh) 用含有18f的有机硅化合物标记的her2结合肽
JP2025106360A (ja) 癌のイメージングおよび治療のための修飾されたgrprアンタゴニストペプチド
EP4631959A2 (en) Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy
JP6410339B2 (ja) 放射性核種標識オクトレオチド誘導体
US20250313579A1 (en) Ligand compounds comprising a chelating group as a bridging group
CN117320759A (zh) 放射性药物生长抑素受体配体及其前体
CN119630622A (zh) 用于放射性药物的硅系氟化物受体基团
WO2025171887A1 (en) Radiolabeled complexes and pharmaceutical compositions including the same
HK1193987A (en) Her2 binding peptides labeled with aluminium-[18] fluoride complexed by nota
HK1191244A (en) Her2 binding peptides labelled with a 18f - containing organosilicon compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination